A paper by Drummond et al. (2023) explores how well being expertise evaluation our bodies are addressing the problem of worth evaluation for cell and gene therapies (often known as Superior Remedy Medicinal Merchandise (ATMPs) in Europe). To do that, the authors:

…undertook i) a targeted assessment of the literature on the medical and financial proof wants for these therapies, and ii) an in-depth evaluation of HTA stories from 8 main jurisdictions for 9 cell and gene therapies throughout 10 indications, along with all related publicly out there paperwork on managed accession agreements and post-launch proof necessities.

The authors used an information extraction kind from Drummond et al. (2019).

The authors study these components and decide to what extent these components are cited positively, negatively or neutrally.

Additionally it is attention-grabbing that though broader or societal worth components had been talked about within the ATMP worth evaluation, this was not all the time the case.

The article is attention-grabbing and you’ll learn the total article right here.